Until eventually a vaccine is in use among the final inhabitants, all potential adverse events with the vaccine may not be identified, requiring brands to carry out Phase IV experiments for postmarketing surveillance of the vaccine even though it is employed widely in the general public.An oral polio vaccine turned out to be efficient when vaccina